Retinal vein occlusion (RVO) is the second most prevalent retinal disease. Despite this, the
pathogenic mechanisms and risk factors are not entirely clear. In this article, we review …

Retinal vein occlusion (RVO) is a disease that is often associated with a variety of systemic
disorders including arterial hypertension, diabetes mellitus, dyslipidemia and systemic …

The effect of the 675 insertion/deletion (4G/5G) polymorphism of plasminogen activator
inhibitor-1 (PAI-1) gene on the risk of venous thromboembolism (VTE) remains controversial …

Essentials• Retinal vein occlusion (RVO), characterized by blood hyperviscosity, has an
unclear pathogenesis.• We aimed to find out if hemorheological profile is altered by …

Several small case-control studies have investigated whether factor V Leiden (FVL) is a risk
factor for retinal vein occlusion (RVO) and generated conflicting data. To clarify this question …

Over the past years, there has been a dramatic increase in the number of identifiable causes
of thrombophilia. However, to date, there are no large, prospective studies to assess an …

Retinal vein occlusion (RVO) is the second most common retinal vein disease and an
important cause of blindness and visual morbidity. Systemic risk factors are commonly …

Retinal vein occlusion (RVO) is a heterogenous disorder in which the formation of a
thrombus results in the retinal venous system narrowing and obstructing venous return from …

Purpose: To investigate atherosclerotic and thrombophilic risk factors in patients affected by
acute ischemic and nonischemic central retinal vein occlusions (CRVOs). Methods: One …

A meta-analysis was performed to assess the association between the PAI-1-675 4G/5G
polymorphism and susceptibility to diabetes mellitus (DM), diabetic nephropathy (DN) …